Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus

US Patent 6225113 · Granted May 1, 2001

Estimated economic value: $822,000

Assignee

Inventors

View full patent text on Google Patents →